164 related articles for article (PubMed ID: 36453428)
41. Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China.
Gao SG; Wang LD; Fan ZM; Li JL; He X; Guo RF; Xie DL; He XW; Gao SS; Guo HQ; Wang JK; Feng XS; Ma BG
World J Gastroenterol; 2005 Aug; 11(30):4634-7. PubMed ID: 16094701
[TBL] [Abstract][Full Text] [Related]
42. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer.
den Hoed CM; Holster IL; Capelle LG; de Vries AC; den Hartog B; Ter Borg F; Biermann K; Kuipers EJ
Endoscopy; 2013; 45(4):249-56. PubMed ID: 23533073
[TBL] [Abstract][Full Text] [Related]
43. Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis.
Shin CM; Kim N; Jung Y; Park JH; Kang GH; Kim JS; Jung HC; Song IS
Cancer Sci; 2010 Jun; 101(6):1337-46. PubMed ID: 20345486
[TBL] [Abstract][Full Text] [Related]
44. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
Park SY; Yoo EJ; Cho NY; Kim N; Kang GH
J Pathol; 2009 Dec; 219(4):410-6. PubMed ID: 19639607
[TBL] [Abstract][Full Text] [Related]
45. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
46. EYA4 Acts as a New Tumor Suppressor Gene in Colorectal Cancer.
Kim SJ; Tae CH; Hong SN; Min BH; Chang DK; Rhee PL; Kim JJ; Kim HC; Kim DH; Kim YH
Mol Carcinog; 2015 Dec; 54(12):1748-57. PubMed ID: 25620232
[TBL] [Abstract][Full Text] [Related]
47. [Intestinal metaplasia at the esophagogastric junction. Prevelence and association in patients undergoing endoscopy].
Castro ML; Fachal C; Pineda JR; Domínguez F; Prada JI; Hermo JA; Suso J; Clofent J
Gastroenterol Hepatol; 2002 Oct; 25(8):487-92. PubMed ID: 12361529
[TBL] [Abstract][Full Text] [Related]
48. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
49. Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia.
Ruol A; Parenti A; Zaninotto G; Merigliano S; Costantini M; Cagol M; Alfieri R; Bonavina L; Peracchia A; Ancona E
Cancer; 2000 Jun; 88(11):2520-8. PubMed ID: 10861428
[TBL] [Abstract][Full Text] [Related]
50. Long-term follow-up of intestinal metaplasia of the gastric cardia.
Morales TG; Camargo E; Bhattacharyya A; Sampliner RE
Am J Gastroenterol; 2000 Jul; 95(7):1677-80. PubMed ID: 10925967
[TBL] [Abstract][Full Text] [Related]
51. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis.
Kang GH; Lee S; Kim JS; Jung HY
Lab Invest; 2003 Apr; 83(4):519-26. PubMed ID: 12695555
[TBL] [Abstract][Full Text] [Related]
52. Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: A large-scale study from low prevalence area of gastric cancer (IM-HP trial).
Aumpan N; Vilaichone RK; Nunanan P; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Pornthisarn B; Uchida T; Vilaichone V; Wongcha-Um A; Yamaoka Y; Mahachai V
PLoS One; 2020; 15(10):e0239434. PubMed ID: 33002050
[TBL] [Abstract][Full Text] [Related]
53. Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach.
Lin CK; Lai KH; Lo GH; Cheng JS; Hsu PI; Mok KT; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):331-6. PubMed ID: 11534800
[TBL] [Abstract][Full Text] [Related]
54. Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication.
Morales TG; Sampliner RE; Camargo E; Marquis S; Garewal HS; Fennerty MB
J Clin Gastroenterol; 2001; 32(5):400-4. PubMed ID: 11319310
[TBL] [Abstract][Full Text] [Related]
55. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis.
Voutilainen M; Färkkilä M; Juhola M; Mecklin JP; Sipponen P
Gut; 1999 Nov; 45(5):644-8. PubMed ID: 10517897
[TBL] [Abstract][Full Text] [Related]
56. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
57. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy.
Byrne JP; Bhatnagar S; Hamid B; Armstrong GR; Attwood SE
Am J Gastroenterol; 1999 Jan; 94(1):98-103. PubMed ID: 9934738
[TBL] [Abstract][Full Text] [Related]
58. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
59. Recognition of goblet cells upon endocytoscopy indicates the presence of gastric intestinal metaplasia.
Chiu PW; Ng EK; To KF; Teoh AY; Lam CC; Chan FK; Sung JJ; Lau JY
Dig Endosc; 2014 Jan; 26(1):52-6. PubMed ID: 23551261
[TBL] [Abstract][Full Text] [Related]
60. Determination of an Appropriate Endoscopic Monitoring Interval for Patients with Gastric Precancerous Conditions in China.
Zhao K; Feng LN; Xia SH; Zhou WD; Zhang MY; Zhang Y; Dong RN; Tian DA; Liu M; Liao JZ
Curr Med Sci; 2023 Apr; 43(2):268-273. PubMed ID: 36864248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
